The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Research Network to Promote Multidisciplinary Mechanistic and Translational Studies of Sickle Cell Disease Pain (U24, Clinical Trial Optional)
The purpose of this FOA is to support a Research Network that promotes multidisciplinary mechanistic and translational studies of Sickle Cell Disease (SCD) pain. This network is expected to develop compelling research frameworks and model systems that will support interdisciplinary collaborations; initiate pilot projects to test novel mechanistic hypotheses in the high-priority research areas listed below and develop novel technologies and methodologies to study pain in the organ(s) typically impacted by SCD. To accomplish these objectives, applicants can propose activities such as meetings, workshops, conferences, research collaborations, exchange of ideas through visiting scientist arrangements, or training opportunities. These activities will help identify unique research gaps and opportunities that can be addressed through the network in the form of pilot projects which will in turn generate the preliminary data needed for SCD pain investigators to successfully compete for more substantial NIH grants, including The Helping to End Addiction Long-term® (HEAL) Initiative grant awards. In addition, the network shall sustain its scientific impact through a variety of dissemination and outreach strategies, including publication of research frameworks, reviews, and other best practices to foster the growth and development of research in the following priority areas:
Required priority areas:
- Developing innovative measures and methods to study pain in individuals affected by SCD or in appropriate model systems
- Exploring novel mechanistic insights of pain in organ(s) impacted by SCD in appropriate animal models or other model systems through reverse translational studies
Optional priority areas:
- Developing new technologies for the identification of biomarkers predicting the transition from acute to chronic SCD pain, pain severity, and heterogeneity in different individuals, as well as its response to complementary and integrative health interventions and other therapies in human subjects or animal models.
- Investigating a Whole Person Health approach to SCD pain and its comorbidities in human subjects or animal models.
- Developing new methodologies for multimodal interventions for acute and/or chronic SCD pain relief (for example, acupuncture with mindfulness) in human subjects or animal models.
- Identifying potential therapeutic targets for complementary and integrative health approaches to acute and/or chronic SCD pain in human subjects, animal models
Applications must propose new, high-impact activities to advance at least the first two required areas (minimum) and up to three optional areas (maximum) of these high-priority research areas.
Letter of Intent Due Date(s): Sep. 1, 2023
Application Due Date: Oct. 1, 2023
RFA-AT-24-001 Expiration Date October 02, 2023
Application budgets are limited to $600,000 in direct costs per year
The scope of the proposed project should determine the project period. The maximum project period is 5 years